Singapore markets close in 15 minutes

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
67.42-0.54 (-0.79%)
At close: 04:00PM EDT
67.95 +0.53 (+0.79%)
Pre-market: 04:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close67.96
Open68.05
Bid0.00 x 800
Ask0.00 x 1000
Day's range67.21 - 68.20
52-week range48.35 - 69.21
Volume5,946,430
Avg. volume6,331,682
Market cap99.101B
Beta (5Y monthly)0.79
PE ratio (TTM)63.01
EPS (TTM)1.07
Earnings date24 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est73.75
  • Benzinga

    FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'

    On Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recalled Obsidio Embolic by issuing a correction. The FDA has identified this as a Class I recall, the most severe type of recall. An investigation determined that delivery of Obsidio Embolic using the aliquot technique, a commonly used delivery method in embolization procedures, for lower gastrointestinal (GI) bleeding embolization, implies a high risk of bowel ischemia. The most serious and the most common adverse health consequenc

  • Reuters

    UPDATE 1-FDA classifies recall of Boston Scientific device as 'most serious'

    The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's device used to block blood flow during excessive bleeding or hemorrhaging as "most serious". An investigation showed that Boston's device, Obsidio Embolic, when used with a specific technique posed a higher risk of bowel ischemia during procedures to stop gastrointestinal (GI) bleeding, the agency said. Bowel ischemia describes disorders that occur when blood flow to your intestines decrease, causing severe abdominal pain.

  • Zacks

    What's in Store for Boston Scientific (BSX) in Q1 Earnings?

    Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.